Cardiovascular effects of D,L-threo-dihydroxyphenylserine in cats

D E Redmond Jr et al. Toxicol Appl Pharmacol.1975 Nov.

No abstract available

Similar articles

Positive chronotropic effect of threo-3,4-dihydroxyphenylserine as a precursor of noradrenaline in rat isolated atria.
Araki H, Cheng JT, Ohmura I, Tanaka C.Araki H, et al.J Pharm Pharmacol. 1978 Jul;30(7):456-8. doi: 10.1111/j.2042-7158.1978.tb13289.x.J Pharm Pharmacol. 1978.PMID:27618No abstract available.
Diuretic effect of L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, in rats and mice.
Katsube J, Kato T, Katsuyama M, Maeda Y, Nishikawa S, Nakamura M.Katsube J, et al.J Pharm Pharmacol. 1986 Jul;38(7):533-4. doi: 10.1111/j.2042-7158.1986.tb04631.x.J Pharm Pharmacol. 1986.PMID:2875157
The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
Semba J, Takahashi R.Semba J, et al.Psychiatry Res. 1985 Aug;15(4):319-26. doi: 10.1016/0165-1781(85)90069-1.Psychiatry Res. 1985.PMID:3934694
Effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in spinal trigeminal nucleus.
Sasa M, Ohno Y, Nabatame H, Yoshimura N, Takaori S.Sasa M, et al.Brain Res. 1987 Sep 8;420(1):157-61. doi: 10.1016/0006-8993(87)90252-6.Brain Res. 1987.PMID:3119149
Noradrenergic influences on dopaminergic function and the pharmacology of dihydroxyphenylserine (DOPS): implication for Parkinson's disease.
Reches A.Reches A.Clin Neuropharmacol. 1985;8(3):249-59. doi: 10.1097/00002826-198509000-00005.Clin Neuropharmacol. 1985.PMID:3930069Review.No abstract available.

Pharmacokinetic studies of oral L-threo-3,4-dihydroxyphenylserine in normal subjects and patients with familial amyloid polyneuropathy.
Suzuki T, Higa S, Sakoda S, Ueji M, Hayashi A, Takaba Y, Nakajima A.Suzuki T, et al.Eur J Clin Pharmacol. 1982;23(5):463-8. doi: 10.1007/BF00605999.Eur J Clin Pharmacol. 1982.PMID:6818040
Memory effect of DL-threo-3,4-dihydroxyphenylserine (DOPS) in human Korsakoff's disease.
Langlais PJ, Mair RG, Whalen PJ, McCourt W, McEntee WJ.Langlais PJ, et al.Psychopharmacology (Berl). 1988;95(2):250-4. doi: 10.1007/BF00174518.Psychopharmacology (Berl). 1988.PMID:3137605Clinical Trial.